SCHEMBL6977362

SCHEMBL6977362

COc1cc(Nc2nc(C)cc(Cl)n2)cc(OC)c1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ EPHB4 P54760 1/20 0.51
▸ EGFR P00533 2/20 0.49
▸ JAK2 O60674 1/20 0.49
▸ CDK2 P24941 1/20 0.49
▸ PIK3CA P42336 1/20 0.49
▸ PIK3CB P42338 1/20 0.49
▸ PIK3CG P48736 1/20 0.49
▸ PTK2B Q14289 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ PTK2 Q05397 5/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17394819 0.89 POLB (0.56) NPC1RAB9AEPHB4GAAPTK2
SCHEMBL13955883 0.82 IGF1R (0.59) EPHB4EGFRJAK2CDK2PIK3CA
SCHEMBL13325996 0.81 PTK2 (0.62) EPHB4EGFRJAK2CDK2PIK3CA
SCHEMBL1131578 0.78 CDK2 (0.68) EPHB4EGFRJAK2CDK2PIK3CA
SCHEMBL15398857 0.76 PTK2 (0.60) EPHB4EGFRJAK2CDK2PIK3CA
SCHEMBL14088802 0.76 IGF1R (0.62) EPHB4EGFRJAK2CDK2PIK3CA
SCHEMBL16677957 0.76 IGF1R (0.56) EPHB4EGFRCDK2MEN1KMT2A
SCHEMBL6979383 0.74 BRAF (0.60) PTK2POLBMEN1CYP1A2MAPT
SCHEMBL19654192 0.74 KDR (0.55) EPHB4EGFRJAK2CDK2PIK3CA
SCHEMBL3407955 0.73 NPC1 (0.51) NPC1RAB9AEPHB4GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 — — EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 — — US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 — — US disclosed
Send feedback